Literature DB >> 27015617

Prevalence of celiac disease among the Iranian population: A systematic review and meta-analysis of observational studies.

Zeinab Ahadi1, Gita Shafiee, Rezvan Razmandeh, Abbas Ali Keshtkar, Mehri Najafi Sani, Bahar Azemati, Maryam Sanaei, Ramin Heshmat.   

Abstract

BACKGROUND/AIMS: The current systematic review and meta-analysis study assessed the prevalence of celiac disease (CD) in Iran.
MATERIALS AND METHODS: Electronic databases, including MEDLINE, SCOPUS, Web of Science, Cochrane library Collaboration, and Iranian scientific databases, were searched from 1993 to 2013 for English and Persian articles. The following terms were used, alone or combined, "celiac (MeSH)," "ceoliac," "prevalence (MeSH)," and "Iran*." Heterogeneity was assessed using the I2 statistic with a cut-off value of 50%, and the Chi-square test was used to define a statically significant degree of heterogeneity with a p value of <0.10. The publication bias of literatures was assessed by visual examination of the funnel plot and Begger's funnel plot.
RESULTS: Meta-analysis was conducted on seven publications with 9,720 subjects. Overall, the pooled prevalence of CD among the Iranian population was 0.72% [95% confidence interval (CI): 0.62%-0.98%]. There was no significant heterogeneity among the studies (I2=4%, p=0.396). The pooled prevalence of CD on the basis of IgA-anti tissue transglutaminase (tTGA) and tTGA and duodenal biopsy positivity was 0.83% (95% CI: 0.69%-1.14%) and 0.79% (95% CI: 0.66%-1.09%), respectively. No significant publication bias was observed using the funnel plot and Begger's funnel plot.
CONCLUSION: CD prevalence among the Iranian population was approximately similar to that of the American and European populations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27015617     DOI: 10.5152/tjg.2015.150191

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  6 in total

1.  Psychometric properties of the Persian version of the celiac disease adherence test questionnaire.

Authors:  Zeinab Nikniaz; Mohammad Asghari Jafarabadi; Saeideh Ghaffarifar; Zahra Saeedi; Zahra Akbari Namvar; Masood Shirmohammadi
Journal:  BMC Gastroenterol       Date:  2020-07-29       Impact factor: 3.067

Review 2.  Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis.

Authors:  Milad Azami; Gholamreza Badfar; Ghobad Abangah; Leily Mahmoudi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

3.  Evaluation of Medication Package Inserts in Iran.

Authors:  Shahriyar Shahbazi Khamas; Atefeh Jafari; Morvarid Zarif-Yeganeh; Hamidreza Taghvaye-Masoumi
Journal:  J Res Pharm Pract       Date:  2019 Apr-Jun

4.  The Predictive Value of Serum Cytokines for Distinguishing Celiac Disease from Non-Celiac Gluten Sensitivity and Healthy Subjects

Authors:  Fatemeh Masaebi; Mehdi Azizmohammad Looha; Mohammad Rostami-Nejad; Mohamad Amin Pourhoseingholi; Navid Mohseni; Gabriel Samasca; Iulia Lupan; Mostafa Rezaei-Tavirani; Mohammad Reza Zali
Journal:  Iran Biomed J       Date:  2020-06-01

5.  The Persian Translation and validation of the celiac disease quality of life questionnaire (CDQOL).

Authors:  Zeinab Nikniaz; Mohammad Asghari Jafarabadi; Saeedeh Ghaffarifar; Zahra Ravand; Zahra Akbari Namvar; Masood Shirmohammadi
Journal:  Health Qual Life Outcomes       Date:  2021-02-10       Impact factor: 3.186

6.  The effects of IL-8, IL- 6, and IL-1 on the risk of celiac disease: a Bayesian regression analysis.

Authors:  Maryam Nasserinejad; Sadjad Shojaee; Mehdi Ghobakhlou; Elena Lak; Pegah Eslami; Mohamad Amin Pourhoseingholi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.